RE-BVS – Piemonte Repository

Sfoglia per AUTORE
OTTAVIANI E
Collezione AOU Città della Salute di Torino

Items : 6

Upfront intensive treatment analysis of the Italian Cohort Study on FLT3-mutated AML patients (FLAM): The impact of a FLT3 inhibitor addition to standard chemotherapy in the real-life setting. in Cancer / Cancer. 2025 Apr 1;131(7):e35824. doi: 10.1002/cncr.35824.

2025
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Marconi G; Petracci E; Valli I; Volpi R; Zamagni F; Mattei A; Ottaviani E; Bochicchio MT; Bocchia M; Todisco E; Cilloni D; Rigolin GM; Giannini MB; Bernardi M; Romani C; Fracchiolla N; Olivieri A; Albano F; Lunghi M; Cambò B; Candoni A; Scappini B; Chiusolo P; Audisio E; Martelli MP; Martinelli G; Mulè A; Papayannidis C; Azzali I; et alii...

A venetoclax and azacitidine bridge-to-transplant strategy for NPM1-mutated acute myeloid leukaemia in molecular failure. in British journal of haematology / Br J Haematol. 2023 Aug;202(3):599-607. doi: 10.1111/bjh.18887. Epub 2023 May 24.

2023
AO Ordine Mauriziano
AOU Città della Salute di Torino

Martelli MP; Curti A; Papayannidis C; Cavo M; Cardinali V; Sciabolacci S; Forte D; Bandini L; Ottaviani E; Patuelli A; Zingarelli F; Ciruolo R; Nanni J; Cristiano G; Zannoni L; Cignetti A; Audisio E; Brunetti L; Sartor C;

Peripheral blasts are associated with responses to ruxolitinib and outcomes in patients with chronic-phase myelofibrosis. in Cancer / Cancer. 2022 Jul 1;128(13):2449-2454. doi: 10.1002/cncr.34216. Epub 2022 Apr 1.

2022
AOU Città della Salute di Torino

Palandri F; Bartoletti D; Iurlo A; Bonifacio M; Abruzzese E; Caocci G; Elli EM; Auteri G; Tiribelli M; Polverelli N; Miglino M; Heidel FH; Tieghi A; Benevolo G; Beggiato E; Fava C; Cavazzini F; Pugliese N; Binotto G; Bosi C; Martino B; Crugnola M; Ottaviani E; Micucci G; Trawinska MM; Cuneo A; Bocchia M; Krampera M; Pane F; et alii...

An IDO1-related immune gene signature predicts overall survival in acute myeloid leukemia. in Blood advances / Blood Adv. 2022 Jan 11;6(1):87-99. doi: 10.1182/bloodadvances.2021004878.

2022
AOU Città della Salute di Torino

Ragaini S; Wagner S; Marconi G; Parisi S; Sartor C; Nanni J; Cristiano G; Talami A; Olivi M; Ocadlikova D; Ciciarello M; Corradi G; Ottaviani E; Papayannidis C; Paolini S; Vadakekolathu J; Cavo M; Rutella S; Curti A;

Safety profile and impact on survival of tyrosine kinase inhibitors versus conventional therapy in relapse or refractory FLT3 positive acute myeloid leukemia patients. in Leukemia research / Leuk Res. 2021 Feb;101:106497. doi: 10.1016/j.leukres.2020.106497. Epub 2020 Dec 25.

2021
AOU Città della Salute di Torino

Paolini S; Curti A; Bonifazi F; Testoni N; Baldazzi C; Cristiano G; Raffini M; Fontana MC; Parisi S; Ottaviani E; Bochicchio MT; Sartor C; Abbenante MC; Ragaini S; Olivi M; Talami A; Bertamini L; Nanni J; Martinelli G; De Polo S; Marconi G; Cavo M; Papayannidis C;

MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia. in European journal of haematology / Eur J Haematol. 2020 Jul;105(1):47-55. doi: 10.1111/ejh.13406. Epub 2020 Apr 7.

2020
AOU Città della Salute di Torino

Marconi G; Talami A; Abbenante MC; Sartor C; Parisi S; Nanni J; Bertamini L; Ragaini S; Olivi M; de Polo S; Cristiano G; Fontana MC; Bochicchio MT; Ottaviani E; Arpinati M; Sessa M; Baldazzi C; Caso L; Testoni N; Baccarani M; Bonifazi F; Martinelli G; Paolini S; Cavo M; Papayannidis C; Curti A;